penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Alan J. Wein, MD, PhD(hon), FACS
Urology

 
  • Profile Home
  • Appointments
  • Education
  • Societies
  • Research
  • Publications
  • Awards

Administrative Office:
Perelman Center for Advanced Medicine
West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Executive Assistant:
Carol R. Martin 215-662-6755
Administrative Telephone: 215-662-2891

Contact Information (internal use only)

Online Chat with Penn Medicine Experts
Prostate Cancer Treatment
Using Proton Therapy
(6ABC News Link)
 
Dr. Wein

ASCO Recommendations Continue the Debate on PSA Testing (Link)

 

 

Alan J. Wein, MD, FACS, PhD(hon) is Professor and Chief of the Division of Urology at the University of Pennsylvania School of Medicine, and Chief of Urology at the Hospital of the University of Pennsylvania and Director of the Residency Program in Urology at the University of Pennsylvania at the Hospital of the University of Pennsylvania. He is a graduate of Princeton University and received his MD from the University of Pennsylvania School of Medicine. He completed training in Surgery and Urology at the University of Pennsylvania including a fellowship at the Harrison Department of Surgical Research. He has been certified and recertified (voluntary) by the American Board of Urology. He was awarded an honorary Ph.D. from the University of Patras, Greece in September 2005.



Dr. Wein has been recognized nationally and internationally through his many affiliations and professional memberships which include the American Association of Genitourinary Surgeons, Clinical Society of Genitourinary Surgeons, American Surgical Association, Society of Surgical Oncology, Society of Urologic Oncology, Society of Pelvic Surgeons, Society for Urodynamics and Female Urology, Société Internationale d’Urologie, American Urological Association (AUA) and the Royal Society of Medicine. He is a recipient of the Urodynamics Society Lifetime Achievement Award, the F. Brantley Scott Award of the American Foundation for Urologic Diseases, the Hugh Hampton Young Award of the American Urological Association, both the Distinguished Service Award and the Distinguished Contribution Award of the American Urological Association, the Achievement Award of the Interstitial Cystitis Association, the William P. Burpeau Award of the New Jersey Academy of Medicine, the Distinguished Service Award of the Society of Urodynamics and Female Urology, and the Ferdinand C. Valentine Award of the New York Academy of Medicine. He has been the Ramon Guiteras lecturer at the AUA annual meeting, the AUA lecturer of the Société Internationale d’Urologie and the European Association of Urology and the British Journal of Urology lecturer at the British Association of Urological Surgeons. He has served on and chaired numerous medical committees and consultations both domestically and internationally, and has received numerous awards and honors for excellence in the field of Urology. He has served on the American Board of Urology (Vice President), the Examination Committee of the American Urological Association and the Residency Review Committee for Urology (Chair). He has held or does hold editorial positions on many well-respected journals including the Survey Section of the Journal of Urology, Neurourology and Urodynamics, Urology, British Journal of Urology International, International Urogynecology Journal, Current Urology Reports, Current Opinion in Urology, Nature Urology, Investigative Urology, Postgraduate Medicine, Advances in Therapy, Current Bladder Dysfunction Reports, Journal of Pelvic Surgery and LUTS. He has been an editor of the textbook considered to be the gold standard in Urology, Campbell-Walsh Urology, since 1992, and is currently the editor-in-chief.

Dr. Wein has authored or co-authored more than 880 articles and chapters, edited or co-edited 28 books, and have multiple multimedia presentations to his credit. His extensive experience in the field of urology has afforded him the opportunity to participate in numerous invited academic activities, meetings, and courses as a speaker, faculty member and chairperson. He is a prodigious lecturer with over 600 invited academic activities over the course of his career, including the co-chairmanship of the 1st, 2nd, 3rd and 4th International Consultations on Incontinence. Throughout his career, he has been recognized by Philadelphia Magazine and Castle Connolly as a “Top Doc”, and is listed as one of America’s “Best Doctors” by the Best Doctors in America, Inc. His fields of interest are the evaluation and management of urologic cancer, the physiology and pharmacology of the lower urinary tract, the evaluation and management of voiding function and dysfunction including problems related to prostate enlargement, urinary incontinence and neurologic disease.

 
Faculty Appointments
2007 - present Founders Professorship in Urology
(aka) The Alan J. Wein, M.D. Professorship
Perelman School of Medicine
University of Pennsylvania
 
1990 - present Professor of Surgery (Urology) in Radiology
 
1983 - present Professor of Urology (Surgery, with tenure)
Perelman School of Medicine
University of Pennsylvania
 
1976 - 1983 Associate Professor of Urology (Surgery with tenure)
University of Pennsylvania School of Medicine
 
1974 - 1976 Assistant Professor of Urology (Surgery)
University of Pennsylvania School of Medicine
 
1971 - 1972 Instructor in Urology (Surgery)
University of Pennsylvania School of Medicine
 
1969 - 1971 Assistant Instructor in Urology (Surgery),
University of Pennsylvania School of Medicine
 
1967 - 1968 Assistant Instructor in Surgery,
University of Pennsylvania School of Medicine
 
Hospital and Administrative Appointments
1995-2004 Attending Urologist
Penn Presbyterian Medical Center
 
1982 - 1996 Attending Urologist
Veterans Administration Hospital
 
1981 - present Chief of Urology
Hospital of the University of Pennsylvania
 
1981 - present Chairman, Division of Urology
Department of Surgery
Perelman School of Medicine
University of Pennsylvania
 
1980 - 1997 Attending Urologist
Graduate Hospital, Philadelphia
 
1979 - 1981 Acting Chief of Urology
Hospital of the University of Pennsylvania,
Acting Chairman, Division of Urology
University of Pennsylvania School of Medicine
 
1977 - present Associate Surgeon, Pennsylvania Hospital
 
1976 - present Director, Program in Urologic Oncology
Division of Urology
Perelman School of Medicine
University of Pennsylvania
 
1975 - present Director, Residency Program in Urology
Division of Urology
Perelman School of Medicine
University of Pennsylvania
 
1975 - 1977 Consultant in Urology
Philadelphia General Hospital
 
1974 - present Director, Urodynamics Evaluation Center
Division of Urology
Perelman School of Medicine
University of Pennsylvania
 
1974 - present Assistant Surgeon
Children’s Hospital of Philadelphia
 
1974 - 1982 Chief of Urology
Philadelphia Veterans Administration Hospital
 
1974 - 1979 Assistant Chief of Urology
Hospital of the University of Pennsylvania
 
Education/Training
2010 Honorary Professor of the Federal State Institute of Urology
(Ministry of Healthcare and Social Development of the Russian Federation)
 
2008 Wharton School of Business
University of Pennsylvania Executive Training Course
 
2005 Honorary Ph.D. conferred by University of Patras
Patras, Greece
 
1962 - 1966 MD - University of Pennsylvania School of Medicine
 
1958 - 1962 AB - Princeton University
 
Postgraduate Training and Fellowship Appointments
1969 - 1972 Resident in Urology
Hospital of the University of Pennsylvania
 
1968 - 1969 Fellow, Harrison Department of Surgical Research (Urology)
University of Pennsylvania School of Medicine
Venereal Disease Resident Trainee
City of Philadelphia
 
1967 - 1968 Resident in Surgery
Hospital of the University of Pennsylvania
 
1966 - 1967 Mixed Surgical Internship
Hospital of the University of Pennsylvania
 
Military Service
1972 - 1974 Major, MC, United States Army, Division of Urology
Martin Army Hospital, Fort Benning, Georgia
 
Memberships/Societies
 
National and International
  • Alpha Omega Alpha
  • American Academy of Clinical Neurophysiology
  • American Association for the Advancement of Science
  • American Association for the Surgery of Trauma
  • American Association of Clinical Urologists
  • American Association of Genitourinary Surgeons
  • American Cancer Society
  • American Clinical Neurophysiology Society (formerly the American Electroencephalographic Society)
  • American College of Surgeons
  • American Fertility Society
  • American Institute of Ultrasound in Medicine
  • American Medical Association
  • American Medical Foundation
  • American Society for Pharmacology and Experimental Therapeutics
  • American Society of Andrology
  • American Society of Clinical Oncology
  • American Society for Men’s Health
  • American Surgical Association
  • American Uro-Gynecologic Society
  • American Trauma Society
  • American Urological Association
  • American Urological Association Allied
  • Association for Academic Surgery
  • Canadian Urological Association
  • Clinical Society of Genito-Urinary Surgeons
  • Eastern Cooperative Oncologic Group
  • Endourological Society
  • European Association of Urology
  • International Continence Society
  • International Society of Impotence Research
  • Interstitial Cystitis Association
  • National Association for Continence
  • National Association of Veterans Administration Physicians
  • National Kidney Foundation, Inc. Council on Urology
  • New York Academy of Sciences
  • Radiation Therapy Oncology Group
  • Royal Society of Medicine
  • Sexual Medicine Society of North America, Inc.
  • Sigma Xi
  • Simon Foundation
  • Société Internationale d’Urologie
  • Société Internationale de Chirurgie
  • Society for Basic Urological Research
  • Society for Minimally Invasive Surgery
  • Society for the Study of Impotence
  • Society for Sex Therapy and Research
  • Society for Urodynamics and Female Urology-SUFU (Formerly the Urodynamics Society)
  • Society of Government Service Urologists
  • Society of Pelvic Surgeons
  • Society of Surgical Oncology
  • Society of University Surgeons (Life Member, effective 2014)
  • Society of University Urologists
  • Society of Urology Chairs and Program Directors
  • Society of Urologic Cryosurgeons
  • Society of Urologic Oncology (Founding member)
  • University Urologic Forum (now defunct)
  • Urologic Investigators Forum (now defunct)
  • Urologic Research Society
  • Urologists Correspondence Club (now defunct)
 
Local
  • American Urological Association, Mid-Atlantic Section
  • College of Physicians of Philadelphia
  • Delaware Valley Society of Transplant Surgeons
  • John Morgan Society
  • Pennsylvania Medical Association
  • Pennsylvania Society of Oncology Hematology
  • Philadelphia Academy of Surgery
  • Philadelphia County Medical Society
  • Philadelphia Urologic Society
  • Ravdin-Rhoads Surgical Society
  • Urological Association of Pennsylvania
 
Research
 
Clinical and Research Activities and Interests
Dr. Wein's clinical expertise and interests are primarily in the fields of urologic cancer and voiding function and dysfunction. He was one of the founding members of the Society of Urologic Oncology and was elected to membership in the other two groups that are concerned with the evaluation and management of cancer: The American Society of Clinical Oncology and the Society of Surgical Oncology. He has particular interest and expertise in the area of prostate cancer and serves as a member of the International Consultation in prostate cancer. Dr. Wein's expertise in the areas of voiding function and dysfunction are widely acknowledged, particularly in the areas of urinary incontinence, neurogenic dysfunction, overactive bladder, interstitial cystitis, and dysfunction secondary to prostate enlargement. He serves on the International Consultation for both urinary incontinence (of which he is co-chair) and benign prosatic hyperplasia. He has been on the faculty of and directed numerous seminars in these areas. His basic research has been in the area of the physiology and pharmacology of the lower urinary tract, with many important discoveries coming out of his laboratory, beginning in 1970 with progress continuing until the present. These include many of the initial studies on autonomic receptor type and binding in the lower urinary tract; the correlation between pharmacological characteristics and function of the bladder and urethra; the correlation of neuroanatomy, neurophysiology and neuropharmacology of the lower urinary tract, and the effects of outlet obstruction on bladder smooth muscle: anatomy, physiology, pharmacology, and function. His clinical research has been in the areas of urologic cancer (prostate, bladder, kidney, testicle) and in the areas of urinary incontinence, voiding difficulties secondary to prostatic enlargement, to neurologic disease or injury, interstitial cystitis, and in the area of techniques to evaluate patients with voiding problems.
 
Publications
Dr. Wein has over 900 publications in print and has been an editor or co-editor of 28 urologic texts or books. He is currently the Editor-in-Chief of Campbell-Walsh Urology, acknowledged to be the gold standard text in the field. He is a consultant to the American Urological Association Office of Education and is the director of its educational series, Practical Cases in Urology. He currently is on the editorial boards of the following journals: Neurourology and Urodynamics (Deputy Editor), British Journal of Urology International (Associate Editor), Urology (Associate Editor), World Journal of Urology, Family Urology, Current Advances in Therapy, and the International Urogynecology Journal.
 
Publications (last 5 years)
  1. Staskin DR, Wein AJ.  Classification of Lower Urinary Tract Dysfunction in the Female Patient.  In Textbook of Female Urology and Urogynecology, Third Edition, Volume 1.  Published in 2010 by Informa Healthcare (in London, UK and simultaneously in New York, USA).
  2. Smith AL, Wein AJ.  Antimuscarinic Pharmacotherapy for Overactive Bladder:  CML – Urology (Current Medical Literature-Urology) 2010;16(1):1-11
  3. Smith AL, Wein AJ.  Drug treatment of voiding dysfunction in women.  In Cardozo L, Staskin DR (eds):  Textbook of Female Urology and Urogynecology, 3rd Edition, Chapter 42, pp: 418-446.  London: Informa Healthcare, 2010 (accepted, in press).
  4. Smith AL, Wein AJ.  Recent advances in management of bladder overactivity.  F1000 Medicine Reports February 2010, 2:9.  PMID: 20948824
  5. Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, Wein A.  Bladder Pain Syndrome:  International Consultation on Incontinence-Research Society.  Neurourol Urodyn 29(1):191-198, 2010
  6. Abrams P, Cardozo L, Wein A.  The International Consultation on Incontinence, Research Society (ICI-RS).  Neurourology and Urodynamics 2010 April;29(4):596-597
  7. Wyndaele JJ, Bruschini H, Madersbacher H, Moore K, Pontari M, Wein A.  Neurological Patients Need Evidence-Based Urological Care.  Neurourol Urodyn 2010 Apr;29(4):662-669
  8. Resnick MJ, Guzzo TJ, Canter DJ, Tomaszewski JE, Bergy MR, Sonnad S, Wein AJ, Malkowicz SB.  Defining pathologic parameters to predict biochemical failure in patients with positive surgical margins at radical prostatectomy:  Implications for adjuvant radiation therapy. BJU International Vol 105(10)pp.1377-1380(4) May 2010.  (Epub Nov 2009)
  9. Chang S, Gomes CM, Hypolite JA, Marx J, Alanzi J, Zderic SA, Malkowicz B, Wein AJ, Chacko S.  Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein.  Am J Phys – Renal Phys 298(6):F1416-23, Jun 2010.  (Epub April 2010)
  10. Mucksavage P, Mitchell C, Kutikov A, Wein AJ, Torigian D, Malkowicz SB.  Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy. ARTICLE IN PRESS (accepted May 10; received in revised form Jul 12; accepted  Jul 13 2010) Urol Oncol. 2011 Mar 9 [Epub ahead of print]
  11. Jayadevappa R, Schwartz JS, Chhatre S, Gallo JJ, Wein AJ, Malkowicz SB.  The Burden of Out-of-Pocket and Indirect Costs of Prostate Cancer.  The Prostate 2010 Aug;70(11):1255-64
  12. Smith, AL, Wein AJ.  Recent advances in the development of antimuscarinic agents for overactive bladder.  Trends Pharmacol Sci. 2010 Oct:31(10):470-5.  PMID: 20801529
  13. Bishay VL, Crino PB, Wein AJ, Malkowicz SB, Trerotola SO, Soulen MC, Stavropoulos SW.  Embolization of Giant Renal Angiomyolipomas: Technique and Results.  J Vasc Interv Radiol 2010;21:67-72
  14. Mucksavage P, Kutikov A, Magerfleisch L, Van Arsdalen K, Wein AJ, Ramchandani P, Malkowicz SB.  Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference?  BJU International (accepted for publication 8 October 2010) BJU Int. 2011 Feb 23 [Epub ahead of print)
  15. Sehgal SS, Wein AJ, Bing Z, Malkowicz SB, Guzzo TJ.  Neuroendocrine Tumor of the Bladder.  Reviews In Urology, 2010 Fall;12(4):e197-201
  16. Pan XQ, Gonzalez JA, Chang S, Chacko S, Wein AJ, Malykhina AP.  Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways.  Experimental Neurology. 225(2):262-73, 2010 Oct
  17. Valentino RJ, Wood SK, Wein AJ, Zderic SA.  The bladder-brain connection: putative role of corticotrophin-releasing factor.  Nat Rev Urol. 2010 Dec 7 [Epub ahead of print].  Nat Rev Urol 2011 Jan;8(1):19-28
  18. Smith AL, Wein AJ.  Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction. (Review)  Discovery Medicine, 10(55):500-510, 2010 December
  19. Smith AL, Wein AJ.  Estrogen replacement for the Urologist:  Effects on Genitourinary Function.  AUA Update Series 2011 Volume 30, Lesson 8, pp: 69-80
  20. Chhatre Sumedha, Wein AJ, Malkowicz SB, Jayadevappa Ravishanikar.  Racial differences in well-being and cancer concerns in prostate cancer paients.  J Cancer Surviv 2011; 5:182-190 (accepted 7 Jan 2011/published online 28 Jan 2011). 
  21. Northington GM, Basha M, Arya LA, Wein AJ, Chacko S.  Contractile Response of Human Anterior Vaginal Muscularis in Women With and Without Pelvic Organ Prolapse.  Reproductive Sciences  March 2011:18(3);296-303 (published online Dec 2010)
  22. Laryngakis NA, Caesar SR, Berns JS, Wein AJ.  Runner’s Bladder:  Exercise-Induced Hematuria With Lower Urinary Tract Pathology. UroToday Int J. 2011 Apr;4(2):art 19
  23. Resnick MJ, Lee DJ, Magerfleisch L, VanArsdalen KN, Tomaszewski JE, Wein AJ, Malkowicz SB, Guzzo TJ.  Repeat Prostate Biospy and the Incremental Risk of Clinically Insignificant Prostate Cancer.  UROLOGY 77(5):548-552, 2011 May
  24. Boopathi E, Gomes CM, Goldfarb R, John M, Srinivasan VG, Alanzi J, Malkowicz SB, Kathuria H, Zderic SA, Wein AJ, Chacko S.  Transcriptional Repression of Caveolin-1 (CAV1) Gene Expression by GATA-6 in Bladder Smooth Muscle Hypertrophy in Mice and Human Beings.  The American Journal of Pathology (AJP) 2011 May;178(5):2236-51
  25. Smith AL, Ferlise VJ, Wein AJ, Ramchandani P, Rovner ES.  Effect of a 7F Transurethral Catheter on Abdominal Leak Point Pressure Measurement in Men with Post-prostatectomy Incontinence.  UROLOGY 77(5):1188-1193, May 2011
  26. Smith AL, Wein AJ.  Outcomes of pharmacological management of nocturia with non-antidiuretic agents: Does statistically significant equal clinically significant?  British Journal of Urology International May 2011:107;1550-1554
  27. Asfaw TS, Hypolite J, Northington GM, Arya LA, Wein AJ, Malykhina AP.  Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. Am J Physiol Regul Integr Comp Physiol 300:R1392-R1400, June 2011
  28. Smith AL, Wein AJ.  Urinary Incontinence – pharmacotherapy options.  Annals of Medicine.  2011;43(6):461-76. [Epub ahead of print 2011 Jun 3]
  29. Weiss JP, Blaivas JG, Bliwise DL, Dmochowski RR, DuBeau CE, Lowe FC, Petrou SP, Van Kerrebroeck PEV, Rosen RC, Wein AJ.  The evaluation and treatment of nocturia: a consensus statement.  BJU Int July 2011:108(1);6-21
  30. Weiss JP, Wein AJ, van Kerrebroeck P, Dmochowski R, Fitzgerald M, Tikkinen KAO, Abrams P.  Nocturia: New Directions.  Neurourology and Urodynamics 30:700-703 (2011)
  31. Wein A.  Symptom-based diagnosis of overactive bladder: an overview.  CUAJ October 2011;5(5Suppl2):S135-S136
  32. Wein AJ.  Pathophysiology and Classification of Lower Urinary Tract Dysfunction:  Overview.  Campbell-Walsh Urology Tenth Edition, Volume 3, Section XIV, Urine Transport, Storage, and Emptying, Chapter 61, pp 1834-1846.  Elsevier Saunders, Copyright©2012
  33. Wein AJ, Dmochowski RR.  Neuromuscular Dysfunction of the Lower Urinary Tract.  Campbell-Walsh Urology Tenth Edition, Volume 3, Section XIV, Urine Transport, Storage, and Emptying, Chapter 65, pp 1909-1946.  Elsevier Saunders, Copyright©2012
  34. Andersson K-E, Wein AJ.  Pharmacologic Management of Lower Urinary Tract and Emptying Failure.  Campbell-Walsh Urology Tenth Edition, Volume 3, Section XIV, Urine Transport, Storage, and Emptying, Chapter 68, pp 1967-2002.  Elsevier Saunders, Copyright©2012
  35. Wein AJ.  Pathophysiology and Classification of Lower Urinary Tract Dysfunction: Overview.  Campbell-Walsh Urology Tenth Edition Review, Elsevier Saunders, Copyright©2012, Chapter 61, pp 335-339
  36. Wein AJ, Dmochowski RR.  Neuromuscular Dysfunction of the Lower Urinary Tract.  Campbell-Walsh Urology Tenth Edition Review, Elsevier Saunders, Copyright©2012, Chapter 65, pp 351-339-358
  37. Andersson K-E, Wein AJ.  Pharmacologic Management of Lower Urinary Tract Storage and Emptying Failure.  Campbell-Walsh Urology Tenth Edition Review, Elsevier Saunders, Copyright©2012, Chapter 68, pp 363-371
  38. Wehrenberg-Klee E, Clark Timothy WI, Malkowicz SB, Soulen MC, Wein AJ, Mondschein JI, Van Arsdalen K, Guzzo TJ, Stavropoulos SW.  Impact on Renal Function of Percutaneous Thermal Ablation of Renal Masses in Patients in Patients with Preexisting Chronic Kidney Disease.  J Vasc Interv Radiol 2012;23:41-45
  39. Jayadevappa R, Malkowicz SB, Wittink M, Wein AJ, Chhatre S.  Comparison of Distribution- and Anchor-Based Approaches to Infer Changes in Health-Related Quality of Life of Prostate Cancer Survivors.  Health Services Research (early online review March 14, 2012) ©Health Research and Educational Trust DOI: 10.1111/j.1475-6773.2012.01395.x.  PMID:  22417225
  40. Weiss BE, Wein AJ, Malkowicz SB, Guzzo TG.  Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging:  Is transrectal ultrasound suitable to determine which patients should undergo active surveillance?  Urologic Oncology 2012 April 12 [Epub ahead of print].  (also see below #937 for hard copy print date)
  41. Smith AL, Wein AJ.  Contemporary Management of Overactive Bladder.  Postgraduate Medicine 2012;124(1):104-116
  42. Weiss JP, Bosch JLH, Drake M, Dmochowski RR, Hashim H, Hijaz A, Johnson TM, Juul KV, Norgaard JP, Norton P, Robinson D, Tikkinen KAO, Van Kerrebroeck PEV, Wein AJ.  Nocturia Think Tank: Focus on Nocturnal Polyuria: ICI-RS 2011.  Neurourology and Urodynamics 31:330-339 (2012)
  43. Sievert K-D, Amen B, Toomey PA, Robinson D, Milsom I, Koelbl H, Abrams P, Cardozo L, Wein A, Smith AL, Newman DK.  Can We Prevent Incontinence?:  ICI-RS 2011.  Neurourology and Urodynamics 31:390-399 (2012)
  44. Smith AL, Jaffe WI, Wang M, Wein AJ.  Detrusor Overactivity Leak Point Pressure in Women with Urgency Incontinence.  International Urogynecology Journal 2012 April;23(4):443-446
    PMID: 22419382    
  45. Smith AL, Wein AJ.  Predicting the future of urodynamics.  Transl Androl Urol 2012;1(2):76-77.  DOI:  10.3975/j.issn.2223-4683.2012.06.01
  46. Smith AL, Wein AJ.  Clinical trials and overactive bladder: lessons learned.  Clinical Investigation, July 2012;2(7):689-705
  47. Menchen L, Wein AJ, Smith AL.  An appraisal of the Food and Drug Administration warning on Urogynecologic Surgical Mesh.  Curr Urol Rep.  2012;13(3):231-9.  PMID: 22434331
  48. Dmochowski R, Wein AJ.  Lower Urinary Tract Pharmacotherapy for Nocturia.  In Nocturia:Causes, Consequences and Clinical Approaches Weiss JP, Blaivas JG, Van Kerrebroeck PEV, Wein AJ (eds).  Springer Science+Business Media, LLC, 2012, Chapter 8, Pages 127-134
  49. Guzzo TJ, Resnick MJ, Canter DJ, Bivalacqua TJ, Rosen MA, Bergey MR, Magerfleisch L, Tomazewski JE, Wein AJ, Malkowicz SB.  Endorectal T2-Weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urologic Oncology: Seminars and Original Investigations 30(2012);301-305.
  50. Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.  Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.  Int J Radiat Oncol Biol Phys.  2012 Aug 1;83(5):1493-9. doi: 10.1016/j.ijrobp.2011.10.047.  Epub 2012 Mar 6.  PMID:  22401922
  51. Anger JT, Le TX, Nissim HA, Rogo-Gupta L, Rashid R, Behniwal A, Smith AL, Litwin MS, Rodriguez LV, Wein AJ, Malkski SL.  How dry is “OAB-dry”?  Perspectives from patients and physician experts.  J Urol 2012, Nov;188(5):1811-1815, PMID: 22999694
  52. Winters JC, Dmochowski RR, Goldman HG, Herndon CDA, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ.  Urodynamic Studies in Adults:  AUA/SUFU Guideline.  The Journal of Urology, December 2012, Vol 188, Number 6, Part 2 of 2, 2464-2472
  53. Jung OS, Guzzo T, Lee D, Mehler M, Christodouleas J, Deville C, Hollis G, Shah A, Vapiwala N, Wein A, Pauly M, Bekelman JE.  Out-of-pocket expenses and treatment choice for men with prostate cancer.  Urology.  2012 Dec;80(6):1252-7. doi: 10.1016/j.urology.2012.08.027. Epub 2012 Oct 23.  PMID:23102446
  54. Hypolite JA, Lei Q, Chang S, Zderic SA, Butler S, Wein AJ, Malykhina AP, Chacko S. Spontaneous and Evoked Contractions are Regulated by PKC Mediated Signaling in Detrusor Smooth Muscle:  Involvement of BK Channels.  Am J Physiol Renal Physiol 2013 Mar 1;304(5):F451-62
  55. Boopathi E, Hypolite JA, Zderic SA, Mendes Gomes C, Malkowicz B, Liou H-C, Wein AJ, Chacko S. GATA-6 and NF-kB Activate CPI-17 Transcription and Regulate Ca2+ Sensitization of Smooth Muscle Contraction.  Mol Cell Biol. 2013 Mar;33(5):1085-1102
  56. Lee UJ, Scott VCS, Rashid R, Behniwal A, Wein AJ, Maliski SL, Anger JT.  Defining and Managing Overactive Bladder:  Disagreement Among the Experts.  UROLOGY, 81(2):257-262, Feb 2013
  57. Basha ME, Chang S, Burrows LJ, Lassman J, Wein AJ, Moreland RS, Chacko S.  Effect of Estrogen on Molecular and Functional Characteristics of the Rodent Vaginal Muscularis.  Journal of Sexual Medicine (early view, article published online (Epub) Feb 25, 2013).
  58. Osman NI, Chapple CR, Wein AJ.  REVIEW – Nocturia: current concepts and future perspectives.  Acta Physiol 2013;207:53-65
  59. Weiss JP, Blaivas JG, Blanker MH, Bliwise DL, Dmochowski RR, Drake M, DuBeau CE, Hijaz A, Rosen RC, Van Kerrebroeck PEV, Wein AJ.  The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy.  BJU International, 111(5):700-717, May 2013
  60. Smith A, Wein A.  Current Pharmacotherapy of Nocturia.  Expert Opinion Pharmacotherapy 2013 May;14(7):885-94
  61. Rosen RC, Holm-Larsen T, Kupelian V, Wein AJ.  Consequences of Nocturia.  PostGraduate Medicine, 125(4):38-46, July 2013
  62. Marx JO, Basha ME, Mohanan S, Hypolite JA, Chang S, Wein AJ, Zderic SA, Laping NJ, Chacko S.  Effects of Rho-kinase inhibition on myosin light chain phosphorylation and obstruction-induced detrusor overactivity.  International Journal of Urology (2013) The Japanese Urological Association.
    Int J Urol 2014 Mar;21(3):319-24                                         
  63. Chapple C, Dmochowski RR, Wein AJ, et al. Detrusor Underactivity.  In Male Lower Urinary Tract Symptoms, Chapple C, Abrams P (eds.), Societe Internationale d’Urologie (SIU), (ISBN:  978-0-9877465-4-2), Montreal, Canada 2013, pp. 295-330). 
  64. Wein A.  Overactive Bladder:  What are the barriers and how do we manage them?  A review of progress over the last 10 years.  CUAJ September-October 2013;7(9-10Suppl4);S172-S173
  65. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen C-I, Milsom I.  Comorbidities and personal burden of urgency urinary incontinence: a systematic review.  Int J Clin Pract, October 2013;67(10):1015-1033;doi:10.1111/ijcp.12164
  66. Voigt JD, Zappala SM, Vaughan ED, Wein AJ.  The Kallikrein Panel for Prostate Cancer Screening:  Its Economic Impact.  The Prostate—published ahead of print online—October 2013.  PMID:  24166488
  67. Newman DK, Wein AJ.  Office-Based Behavioral Therapy for Management of Incontinence and Other Pelvic Disorders. Urol Clin N Am November 2013, Volume 40, Number 4, 613-635.  http://dx.doi.org/10.1016/j.ucl.2013.07.010
  68. Boopathi DM, Hypolite JA, Raabe T, Change S, Zderic S, Wein AJ, Chacko S.  Amino acid mutations in the caldesmon COOH-terminal functional domain increase force generation in bladder smooth muscle. American Journal of Physiology–Renal Physiology 305(10):F1455-65, 2013 Nov 15
  69. Weiss BE, Wein AJ, Malkowicz SB, Guzzo TG.  Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging:  Is transrectal ultrasound suitable to determine which patients should undergo active surveillance?  Urologic Oncology: Seminars and Original Investigations; 2013 Nov;31(8):1436-40.  PMID:  22503576
  70. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen C-I, Milsom I.  Economic Burden of Urgency Urinary Incontinence in the United States:  A Systematic Review.  Journal of Managed Care Pharmacy, February 2014;20(2):130-140
  71. Weiss JP, Juul KV, Wein AJ.  Management of Nocturia: The Role of Antidiuretic Pharmacology.  Neurourology and Urodynamics 33(Suppl 1):S19-S24 (2014)
  72. Weiss JP, Wein AJ, Van Kerrebroeck P.  Future Research Guidance for Nocturia.  Neurourology and Urodynamics 33:S25 (2014)
  73. Weiss JP, Wein AJ, Van Kerrebroeck P.  Introduction and Meeting Recap.  Neurourology and Urodynamics 33:S1 (2014)
  74. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ.  Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity?  A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis.  European Urology, Feb 2014;65(2):389-398
  75. Abrams P, Cardozo L, Wein A.  Fourth International Consultation on Incontinence – Research Society 2013.  Neurourology and Urodynamics 33:571-572 (2014)
  76. Rosier PFWM, Giarenis I, Valentini FA, Wein A, Cardozo L.  Do Patients With Symptoms and Signs of Lower Urinary Tract Dysfunction Need a Urodynamic Diagnosis?  ICI-RS 2013; Neurourology and Urodynamics 33:581-586 (2014)
  77. Wein AJ, Smith AL.  Lower Urinary Tract Function and Dysfunction; Urinary Incontinence.  Penn Clinical Manual of Urology, Second Edition, 2014, Elsevier/Saunders, Philadelphia, PA, pp 332-461
  78. Guzzo TJ, Malkowicz, SB, Vaughn DJ, Wein AJ.  Adult Genitourinary Cancer: Prostate and Bladder.  Penn Clinical Manual of Urology, Second Edition, 2014, Elsevier/Saunders, Philadelphia, PA, pp 505-546
  79. Pietzak III, EJ, Guzzo TJ, Wein AJ, Resnick MJ.  Adult Genitourinary Cancer: Renal, Testicular, and Penile.  Penn Clinical Manual of Urology, Second Edition, 2014, Elsevier/Saunders, Philadelphia, PA, pp 547-592
  80. Pietzak EJ, Resnick MJ, Mucksavage P, Van Arsdalen K, Wein AJ, Malkowicz SB, Guzzo TJ.  Multiple repeat prostate biopsies and the detection of clinically insignificant cancer in men with large prostates.  Urology. 2014 Aug;84(2):380-5. doi: 10.1016/j.urology.2014.04.029. Epub 2014 Jun 12. PMID:24929944  [PubMed - in process]
  81. Wein AJ.  Normal and Abnormal Function:  An Overview.  In Bladder Dysfunction in the Adult: The Basis for Clinical Management; pp:19-24.  Humana Press/Springer, New York, 2014. ISSN 2197-7194; ISBN: 978-1-4939-0852-3
  82. Wein AJ.  Evaluation:  History and Physical Examination, Imagining and Endoscopy. In Bladder Dysfunction in the Adult: The Basis for Clinical Management; pp:77-83.  Humana Press/Springer, New York, 2014. ISSN 2197-7194; ISBN: 978-1-4939-0852-3
  83. Wein AJ, Newman DK.  Behavioral Therapy.  In Bladder Dysfunction in the Adult: The Basis for Clinical Management; pp:103-112.  Humana Press/Springer, New York, 2014. ISSN 2197-7194; ISBN: 978-1-4939-0852-3
  84. Boopathi E, Gomes C, Zderic SA, Malkowicz B, Chakrabarti R, Patel DP, Wein AJ, Chacko S.  Mechanical stretch up-regulates proteins involved in CA2+-sensitization in urinary bladder smooth muscle hypertrophy.  Articles in Press, Am J Physiol Cell Physiol (August 13, 2014).  doi: 10.1152/ajpcell.00033.2014
  85. Jayadevappa R, Newman DK, Chhatre S, Wein AJ.  Medication adherence in the management of nocturia: challenges and solutions.  Dove Medical Press, Patient Preference and Adherence 2015;9:77-85
  86. Pietzak EJ, Van Arsdalen K, Patel K, Malkowicz SB, Wein AJ, Guzzo TJ.  Impact of Race on Selecting Appropriate Patients for Active Surveillance With Seemingly Low-risk Prostate Cancer.  UROLOGY 85:436-441, 2015
  87. Protein kinase C modulates frequency of micturition and non-voiding contractions in the urinary bladder via neuronal and myogenic mechanisms.  BMC Urology 2015 Apr 21;15(1):34 
Abstracts, Editorials (last 5 years)
  1. Wein AJ.  Urinary Incontinence in Women:  Direct Costs of Routine Care.  J Urol Jan 2010, 183(1):253
  2. Wein AJ.  The Impact of Multichannel Urodynamics Upon Treatment Recommendations for Female Urinary Incontinence.  J Urol Jan 2010, 183(1):253-254
  3. Wein AJ.  Reliability Testing of Urodynamics, Pressure Flow Studies and Cough Leak Point Pressure in Women With Urodynamic Stress Incontinence With and Without Detrusor Overactivity.  J Urol Jan 2010, 183(1):254
  4. Wein AJ.  Clarification and Confirmation of the Knack Maneuver: The Effect of Volitional Pelvic Floor Muscle Contraction to Preempt Expected Stress Incontinence.  J Urol Jan 2010, 183(1):255
  5. Wein AJ.  Radiofrequency Remodelling of the Endopelvic Fascia is Not an Effective Procedure for Urodynamic Stress Incontinence in Women.  J Urol Jan 2010, 183(1):255-256
  6. Wein AJ.  Rate of De Novo Stress Urinary Incontinence After Urethral (sic) Diverticulum Repair.  J Urol Jan 2010, 183(1)256-257
  7. Wein AJ.  Surgical Management of Pelvic Organ Prolapse in Women: A Short Version Cochrane Review.  J Urol Jan 2010, 183(1):257-258
  8. Wein AJ.  Short-Term Results of Bilateral S2-S4 Sacral Neuromodulation for the Treatment of Refractory Interstitial Cystitis, Painful Bladder Syndrome, and Chronic Pelvic Pain.  J Urol Feb 2010, 183(2):570
  9. Wein AJ.  A Positive Modulator of KCa2 and KCa3 Channels, 4,5-Dichloro-1,3-Diethyl-1,3-Dihydro-Benzoimidazol-2-One (NS4591), Inhibits Bladder Afferent Firing in Vitro and Bladder Overactivity In Vivo.  J Urol Feb 2010, 183(2):646
  10. Wein AJ.  Sacral Nerve Stimulation for Neuromodulation of the Lower Urinary Tract.  J Urol Feb 2010, 183(2):646-647
  11. Wein AJ.  Does Urodynamic Verification of Overactive Bladder Determine Treatment Success?  Results from a Randomized Placebo-Controlled Study.  J Urol Feb 2010, 183(2):647-648
  12. Wein AJ.  Catecholamines Relax Detrusor Through b2-Adrenoceptors in Mouse and b3-Adrenoceptors in Man.  J Urol Feb 2010, 183(2):823
  13. Wein AJ.  Do Women With Pure Stress Urinary Incontinence Need Urodynamics?  J Urol Mar 2010, 183(3):1110-1111
  14. Wein AJ.  Follow-Up of TVT Operations in 1,113 Women With Mixed Urinary Incontinence at 7 and 38 Months.  J Urol Mar 2010, 183(3):1111-1112
  15. Wein AJ.  A Systematic Review of Overweight and Obesity as Risk Factors and Targets for Clinical Intervention for Urinary Incontinence in Women.  J Urol Apr 2010, 183(4):1479-1480
  16. Wein AJ.  Basic Mechanisms of Urgency:  Preclinical and Clinical Evidence.  J Urol Apr 2010, 183(4):1480-1481
  17. Wein AJ.  Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes:  Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.  J Urol May 2010, 183(5):1927-1928
  18. Wein AJ.  Urinary and Erectile Dysfunction in Multiple System Atrophy (MSA).  J Urol May 2010, 183(5):1928-1929
  19. Wein AJ.  Prophylactic Antibiotics in Urodynamics:  A Systematic Review of Effectiveness and Safety.  J Urol June 2010, 183(6):2275
  20. Wein AJ.  Evaluation and Outcome Measures in the Treatment of Female Urinary Stress Incontinence:  International Urogynecological Association (IUGA) Guidelines for Research and Clinical Practice.  J Urol June 2010, 183(6):2276
  21. Wein AJ.  Nocturia, Nocturnal Incontinence Prevalence, and Response to Anticholinergic and Behavioral Therapy.  J Urol June 2010, 183(6):2277
  22. Wein AJ.  Enhanced Bladder Capacity and Reduced Prostaglandin E2-Mediated Bladder Hyperactivity in EP3 Receptor Knockout Mice.  J Urol June 2010, 183(6):2463-2464
  23. Wein AJ.  Long-Lasting Breaches in the Bladder Epithelium Lead to Storage Dysfunction With Increase in Bladder PGE2 Levels in the Rat.  J Urol June 2010, 183(6):2464-2465
  24. Hypolite J, Chang S, Zderic S, Wein A, Butler S, Chacko S.  Role of Myosin Light Chain Phosphorylation in Partial Bladder Outlet Obstruction:  Compensated Versus Decompensated.  Abstract 183, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010.  J Urol 183(4):e73A
  25. Hypolite J, Chang S, Zderic S, Wein A, Butler S, Chacko S.  Large Conductance Calcium-And Voltage-Activated Potassium Channel (BK) Opener Inhibits Spontaneous Overactive Contraction of Detrusor Smooth Muscle in Obstructed Bladders.  Abstract 186, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010. J Urol 2010:183(4):e74A
  26. Resnick M, Lee D, Van Arsdalen K, Wein A, Malkowicz SB, Guzzo T.  Repeat Prostate Biopsy and the Incremental Risk of Clinically Insignificant Prostate Cancer.  Abstract 247, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010
  27. Stansell L, Newman D, Magerfleisch L, Wein A, Guzzo T, Malkowicz SB.  Increased Basal Resting Tone During EMG Biofeedback is Associated with Improved Voiding for Patients with Orthotopic Neobladder Dysfunction.  Abstract 749, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010
  28. Asfaw T, Hypolite J, Northington G, Arya L, Wein A, Malykhina A.  Diminished Detrusor Muscle Contractility Underlies the Urinary Bladder Dysfunction Induced by Experimental Colitis:  Mechanism For Pelvic Organ Cross-Talk.  Abstract 1001, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010
  29. Lei Q, Pan X-Q, Wein A, Malykhina A.  Acute Inflammation in the Pelvis Modulates the Excitability of Bladder Extrinsic Sensory Neurons Via Activation of Voltage Gated Sodium Channels and Non-Selective Cation Channels.  Abstract 1002, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010
  30. Chang S, Alanzi J, Hanno PM, Newman DK, Northington G, Wein AJ, Chacko S.  Endothelin-1 as a Regulator of Urothelial Cell Proliferation and a Potential Urinary Biomarker in Interstitial Cystitis(IC).  Abstract 1042, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010.  J Urol 2010:183(4):e405-e406A
  31. Boopathi E, Hypolite J, Liou H-C, Wein A, Chacko S.  Transcription Factor NF-KB is Required for Gene Expression of a 17-KDA PKC-Potentiated Inhibitory Protein of Protein Phosphatase-1 (CPI-17) and PKC-Mediated Signal Transduction of Detrusor Smooth Muscle Contraction.  Abstract 1685, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, June 1, 2010; J Urol 2010:183(4):e651A
  32. Wein AJ.  Gene Therapy for Bladder Overactivity and Nociception With Herpes Simplex Virus Vectors Expressing Preproenkephalin.  J Urol July 2010, 184(1):224
  33. Wein AJ.  Neuromuscular Electrical Stimulation and the Treatment of Lower Urinary Tract Dysfunction in Multiple Sclerosis – A Double Blind, Placebo Controlled, Randomised Clinical Trial.  J Urol July 2010, 184(1):225
  34. Wein AJ.  1) Botulinum Injections for the Treatment of Bladder Symptoms of Multiple Sclerosis;
    2) Neurogenic Detrusor Overactivity Treated With English Botulinum Toxin A:  8-Year Experience of One Single Centre.  J Urol July 2010, 184(1):226-227
  35. Wein AJ.  Bladder Diary Measurements in Asymptomatic Males:  Frequency, Volume per Void, and 24-Hr Volume.  J Urol August 2010, 184(2):643
  36. Wein AJ.  Do alpha1-Adrenoceptor Antagonists Improve Lower Urinary Tract Symptoms by Reducing Bladder Outlet Resistance?  J Urol August 2010, 184(2):643-644
  37. Wein AJ.  Ileovesicostomy for Adults With Neurogenic Bladders:  Complications and Potential Risk Factors for Adverse Outcomes.  J Urol August 2010, 184(2):644-645
  38. Wein AJ.  Incontinent Ileovesicostomy:  Long-Term Outcomes and Complications.  J Urol August 2010, 184(2):645-646
  39. Wein AJ.  Prospective Pharmacologic Therapies for the Overactive Bladder.  J Urol August 2010, 184(2):800-801
  40. Wein AJ1) The Evolving Physiology of the Lower Urinary Tract:  What We are Learning and Where We Need to Go.  2) Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-Dihydro-1H-Inden-4-yl)-3-(2-(Piperidin-1-yl)-4-(Trifluoromethyl)Phenyl)-Acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats.  3) AMTB, a TRPM8 Channel Blocker: Evidence in Rats for Activity in Overactive Bladder and Painful Bladder Syndrome.  J Urol August 2010, 184(2):801-803
  41. Wein AJ.  1) Chronic Suprapubic Catheterization in the Management of Patients With Spinal Cord Injuries:  Analysis of Upper and Lower Urinary Tract Complications.  2)  Contemporary Role of Suprapubic Cystostomy in Treatment of Neuropathic Bladder Dysfunction in Spinal Cord Injured Patients.  J Urol September 2010, 184(3):997-999
  42. Wein AJ.  Defining Success Following Sling Surgery: Association of Satisfaction With Patient Reported Outcomes.  J Urol September 2010, 184(3):1045-1046
  43. Wein AJ.  Predictors of Persistent Detrusor Overactivity After Transvaginal Sling Procedures.  J Urol September 2010, 184(3):1046-1047
  44. Wein AJ.  Pregnancy and Delivery After Mid-Urethral Sling Procedures for Stress Urinary Incontinence:  Case Reports and a Review of Literature.  J Urol September 2010, 184(3):1047-1048
  45. Wein AJ.  Follow-Up of TVT Operations in 1,113 Women With Mixed Urinary Incontinence at 7 and 38 Months.  J Urol September 2010, 184(3):1048
  46. Wein AJ.  A 5-Year Prospective Follow-Up Study of Vaginal Surgery for Pelvic Organ Prolapse.  J Urol September 2010, 184(3):1049
  47. Wein AJ.  Sacral Neuromodulation for Urinary Retention. J Urol September 2010, 184(3):1049-1050
  48. Wein AJ.  Is it possible to diagnosis intrinsic sphincter deficiency in women?  J Urol October 2010, 184(4):1419
  49. Wein AJ.  A review of the concordance of diagnoses made after multi-channel urodynamics and video urodynamics in women with urinary incontinence.  J Urol October 2010, 184(4):1420
  50. Wein AJ.  The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: The Colpopexy and urinary reduction efforts (CARE) randomized surgical trial.  J Urol October 2010, 184(4):1421
  51. Wein AJ.  “The Cough Game”:  Are there characteristic urethrovesical movement patterns associated with stress incontinence?  J Urol October 2010, 184(4):1421-1422
  52. Wein AJ.  Obstructive voiding symptoms are not predictive of elevated postvoid residual urine volumes.  J Urol October 2010, 184(4):1422-1423
  53. Wein AJ.  Differences between the data from free flow and intubated flow in women with urinary incontinence.  What do they mean?  J Urol October 2010, 184(4):1423
  54. Wein AJ.  Bladder Control, Urgency, and Urge Incontinence: Evidence From Functional Brain Imaging.  J Urol November 2010, 184(5):2029
  55. Wein AJ.  Practical Aspects of Lifestyle Modifications and Behavioural Interventions in the Treatment of Overactive Bladder and Urgency Urinary Incontinence.  J Urol November 2010, 184(5):2030
  56. Wein AJ.  Randomized, Placebo-Controlled Trial of the Cognitive Effect, Safety, and Tolerability of Oral Extended-Release Oxybutynin in Cognitively Impaired Nursing Home Residents With Urge Urinary Incontinence.  J Urol November 2010, 184(5):2030-2031
  57. Wein AJ.  Has Botulinum Toxin Therapy Come of Age:  What Do We Know, What Do We Need to Know, and Should We Use It?  J Urol November 2010, 184(5):2031-2032
  58. Wein AJ.  Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions:  A European Consensus Report.  J Urol November 2010, 184(5):2032-2033
  59. Wein AJ.  Duloxetine 1 Year On:  The Long-Term Outcome of a Cohort of Women Prescribed Duloxetine.  J Urol November 2010, 184(5):2033
  60. Wein AJ.  The Destruction of the Lower Urinary Tract by Ketamine Abuse:  A New Syndrome?  J Urol November 2010, 184(5):2034
  61. Wein AJ.  Effect of Long-Term Oxybutynin Administration on C-Fos Expression in Spinal Neurons:  Inhibition of Antimuscarinics on Bladder Afferents in Conscious Rats.  J Urol November 2010, 184(5):2209-2210
  62. Wein AJ.  Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women.  J Urol December 2010, 184(6):2456-2457
  63. Wein AJ.  Retropubic Versus Transobturator Midurethral Slings for Stress Incontinence.  J Urol December 2010, 184(6):2457-2458
  64. Wein AJ.  Urinary Dysfunction in Parkinson’s Disease: A Review.  J Urol January 2011, 185(1):224
  65. Wein AJ.  The Effect of Bladder Outlet Obstruction on alpha1- and beta-Adrenoceptor Expression and Function.  J Urol Jan 2011, 185(1):355
  66. Wein AJ.  Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms.  J Urol Feb 2011, 185(2):600-601
  67. Wein AJ.  The Impact of Lower Urinary Tract Symptoms and Urinary Incontinence on Female Sexual Dysfunction Using a Validated Instrument.  J Urol Feb 2011, 185(2):601-602
  68. Wein AJ.  Outcome Measure for Stress Urinary Incontinence Treatment (OMIT): Results of Two Society of Urodynamics and Female Urology (SUFU) Surveys.  J Urol Mar 2011, 185(3):1010-1011
  69. Wein AJ.  Continence Pessary Compared With Behavioral Therapy or Combined Therapy for Stress Incontinence: A Randomized Controlled Trial.  J Urol Mar 2011, 185(3):1011-1012
  70. Wein AJ.  Updated Systematic Review and Meta-Analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence.  J Urol Mar 2011, 185(3):1012-1013
  71. Wein AJ.  Defining the Role of Urodynamics in Predicting Voiding Dysfunction After Anti-incontinence Surgery: A Work in Progress.  J Urol Mar 2011, 185(3):1013
  72. Smith AL, Wang M, Jaffe WI, Wein AJ.  Detrusor leak point pressure (DLPP) in non-neurogenic women with urge incontinence SUFU Mar 2011, Arizona
  73. Wein AJ.  Visceral Organ Cross-Sensitization—An Integrated Perspective.  J Urol Apr 2011, 185(4):1379
  74. Wein AJ.  Stem Cell Therapy for Stress Urinary Incontinence.  J Urol Apr 2011, 185(4):1379-1380
  75. Wein AJ.  Antimuscarinics and Bladder Outlet Obstruction: From a Contraindication to an Indication?  J Urol Apr 2011, 185(4):1380-1381
  76. Wein AJ.  Urethral Versus Suprapubic Catheter: Choosing the Best Bladder Management for Male Spinal Cord Injury Patients With Indwelling Catheters.  J Urol Apr 2011, 185(4):1381
  77. Wein AJ.  Transabdominal Ultrasonography of Detrusor Wall Thickness in Women With Overactive Bladder.  J Urol May 2011, 185(5):1811
  78. Wein AJ.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction.  J Urol May 2011, 185(5):1812
  79. Wein AJ.  Parity is Not Associated With Urgency With or Without Urinary Incontinence.  J Urol May 2011, 185(5) 1813
  80. Wein AJ.  The Use of Mesh in Vaginal Prolapse Repair: Do the Benefits Justify the Risks?  J Urol May 2011, 185(5) 1813
  81. Boopathi E, Hypolite J, Chang S, Liou H-C, Zderic S, Wein A, Chacko S.  Downregulation of NF-&[KAPPA]B Inhibits PKC-Mediated Smooth Muscle Contraction and Induce Non-Voiding Contractions in Murine Bladder.  (Abstract #1947, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)
  82. Boopathi E, Gomes C, Goldfard R, John M, Srinivasan V, Alanzi J, Malkowicz SB, Kathuria H, Zderic S, Wein A, Chacko S.  Caveolin-1 Gene Expression is Down Regulated in Bladder Smooth Muscle Hypertrophy in Mice and Humans with PBOO.  (Abstract #1948, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)
  83. Boopathi E, Zderic S, Wein A, Chacko S.  Temporal Gene Expression Profiling of Proteins Involved in CA2+-Sensitization Following Partial Bladder Outlet Obstruction: Mechanism for Upregulation of RHOA and ROKβ Gene Expression.  (Abstract #1949, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)
  84. Hypolite J, Lei Q, Chang S, Malykhina A, Zderic S, Wein A, Butler S, Chacko S.  Protein Kinase C Inhibits Spontaneous and Non-Voiding Contractions in Detrusor Smooth Muscle: Role and Interaction With BK Channels.  (Abstract #1950, presented at the Annual Meeting of the American Urological Association, Washington, DC, May 17, 2011)
  85. Wein AJ.  Effects of Cl316,243, a Beta 3-Adrenoceptor Agonist, and Intravesical Postaglandin E2 on the Primary Bladder Afferent Activity of the Rat.  J Urol May 2011, 185(5):1978-1979
  86. Wein AJ.  What is the Predictive Value of Urodynamics to Reproduce Clinical Findings of Urinary Frequency, Urge Urinary Incontinence, and/or Stress Urinary Incontinence?  J Urol Jun 2011, 185(6):2260-2261
  87. Wein AJ.  Bladder Dysfunction in Hereditary Spastic Paraplegia:  What to Expect?  J Urol Jun 2011, 185(6):2261
  88. Wein AJ.  Vulvovaginal Atrophy.  J Urol Jun 2011, 185(6):2262
  89. Wein AJ.  Cystoscopic Injections of Dextranomer Hyaluronic Acid Into Proximal Urethra for Urethral Incompetence:  Efficacy and Adverse Outcomes.  J Urol Jun 2011, 185(6):2262
  90. Wein AJ.  Systemic Adverse Events Following Botulinum Toxin A Therapy in Children With Cerebral Palsy.  J Urol Jun 2011, 185(6):2347
  91. Wein AJ.  Intravesical Botulinum Toxin A Injections in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis:  A Systematic Review.  J Urol Jul 2011, 186(1):133-134
  92. Wein AJ.  The Science Behind Biomaterials in Female Stress Urinary Incontinence Surgery. 
    J Urol Jul 2011, 186(1):209-210
  93. Wein AJ.  A Randomized Trial Comparing Tension-Free Vaginal Tape With Tension-Free Vaginal Tape-Obturator: 36-Month Results.  J Urol Jul 2011, 186(1):210
  94. Wein AJ.  Long-Term Efficacy of the Tension-Free Vaginal Tape Procedure for the Treatment of Urinary Incontinence:  A Retrospective Follow-Up 11.5 Years Post-Operatively.  J Urol Jul 2011, 186(1):210-211
  95. Wein AJ.  Is Mid-Urethral Placement of Synthetic Minimal Access Tapes Important in Stress Urinary Incontinence Surgery?  J Urol Jul 2011, 186(1):211
  96. Wein AJ.  Post-Prostatectomy Stress Urinary Incontinence: What Treatment for Which Patient?  J Urol Aug 2011, 186(2):536
  97. Wein AJ.  Male Incontinence Surgery in the 21st Century: Past, Present and Future.  J Urol Aug 2011, 186(2):536-537
  98. Wein AJ.  Cross-Talk and Sensitization of Bladder Afferent Nerves.  J Urol Aug 2011, 186(2):615
  99. Wein AJ.  A Decade of Functional Brain Imaging Applied to Bladder Control.  J Urol Aug 2011, 186(2):615-616
  100. Wein AJ.  Sacral Neuromodulation in Diabetic Patients: Success and Complications in the Treatment of Voiding Dysfunction.  J Urol Aug 2011, 186(2):616-617
  101. Wein AJ.  Physiotherapy as an Adjunct to Prolapse Surgery:  An Assessor-Blinded Randomized Controlled Trial.  J Urol Aug 2011, 186(2):617
  102. Wein AJ.  International Consultation on Incontinence-Research Society (ICI-RS) Report on Non-Invasive Urodynamics:  The Need of Standardization of Ultrasound Bladder and Detrusor Wall Thickness Measurements  to Quantify Bladder Wall Hypertrophy. J Urol Sept 2011, 186(3):986-987
  103. Wein AJ.  Dynamic Progression of Overactive Bladder and Urinary Incontinence Symptoms: A Systematic Review.  J Urol Sept 2011, 186(3):987-988
  104. Wein AJ.  Re: An Update on Sacral Neuromodulation:  Where Do We Stand With This In The Management of Lower Urinary Tract Dysfunction in 2010?  J Urol Oct 2011, 186(4)Part 1of2:1376
  105. Wein AJ.  Re: Is Robotic Sacrocolpopexy a Marketing Gimmick or a Technological Advancement? J Urol Oct 2011, 186(4)Part 1of2:1376-1377
  106. Wein AJ.  Re: Behavioral Therapy With or Without Biofeedback and Pelvic Floor Electrical Stimulation for Persistent Postprostatectomy Incontinence: A Randomized Controlled Trial.  J Urol Oct 2011, 186(4)Part 1of2:1377-1378
  107. Wein AJ.  Re: Surgical Approach to Incontinence.  Preface.  J Urol Oct 2011, 186(4)Part 1of2:1378
  108. Wein AJ.  Re: The Role of the Transient Receptor Potential (TRP) Superfamily of Cation-Selective Channels in the Management of the Overactive Bladder. Re: Sensor Mechanism and Afferent Signal Transduction of the Urinary Bladder: Special Focus on Transient Receptor Potential Ion Channels. 
    J Urol Nov 2011;186(5):2125-2126
  109. Wein AJ. Re: Urothelial Signaling. Re: Interstitial Cells in the Urinary Bladder-Localization and Function. Re: Detrusor Myocyte Activity and Afferent Signaling.  J Urol Nov 2011;186(5):2127-2128
  110. Wein AJ. Re: Effects of Phenazopyridine on Rat Bladder Primary Afferent Activity, and Comparison With Lidocaine and Acetaminophen.  J Urol Nov 2011;186(5):2128-2129
  111. Wein AJ.  Re: FDA Safety Communication:  Update on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse – U.S. Food and Drug Administration.  Re:  Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse – U.S. Food and Drug Administration Center for Devices and Radiological Health.  Re: American Urogynecologic Society (AUGS) Response: FDA Safety Communication:  Update on Serious Complications Associated With Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse (July 2011).  Re: Society for Female Urology and Urodynamics (SUFU) Response: FDA Safety Communication: Update on Serious Complications Associated With Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse (July 2011) J Urol Dec 2011;186(6):2328-2330
  112. Wein AJ.  Re: Urodynamics, the Supine Empty Bladder Stress Test, and Incontinence Severity.  J Urol Jan 2012;187(1):201-202
  113. Wein AJ, Penson DF.  Re: Retropubic Versus Transobturator Midurethral Slings for Stress Incontinence.  Re: Transobturator TVT-O Versus Retropubic TVT: Results of a Multicenter Randomized Controlled Trial at 24 Months Follow-Up.  Re: What Patients Think: Patient-Reported Outcomes of Retropubic Versus Trans-Obturator Mid-Urethral Slings for Urodynamic Stress Incontinence—A Multi-Centre Randomised Controlled Trial.  J Urol Jan 2012;187(1):202-205
  114. Wein AJ.  Re: Should an Anti-Incontinence Procedure be Routinely Performed at the Time of Pelvic Organ Prolapse Repair?  An Evidence-Based Review.  J Urol Jan 2012;187(1):205
  115. Wein AJ.  Re: Are Multichannel Urodynamics Required Prior to Surgery in a Woman With Stress Urinary Incontinence?  J Urol Jan 2012;187(1):206
  116. Wein AJ.  Re: Mixed Incontinence: Comparing Definitions in Non-Surgical Patients.  J Urol Feb 2012;187(2):580
  117. Wein AJ.  Re: National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age.  J Urol Feb 2012;187(2):581
  118. Wein AJ.  Re: Patient Satisfaction With the Benefits of Overactive Bladder Treatment Exploration of Influencing Factors and Development of a Satisfaction Assessment Instrument.  J Urol Feb 2012;187(2):582
  119. Wein AJ.  Re: Current Status of Urodynamics for Evaluation of Incontinence.  J Urol Mar 2012;187(3):962-963
  120. Wein AJ.  Re:  Abdominal Diurnal Rhythm of Urine Output Following Renal Transplantation: The Impact of Blood Pressure and Diuretics.  J Urol Mar 2012;187(3):964
  121. Wein AJ.  Re:  Pediatric Kidney Recipients With Small Capacity, Defunctionalized Urinary Bladders Receiving Adult-Sized Kidney Without Prior Bladder Augmentation.  J Urol Mar 2012;187(3):1056
  122. Wein AJ.  Re:  Validation of the Urinary Sensation Scale (USS).  J Urol Apr 2012;187(4):352-1353
  123. Wein AJ.  Re:  Perceptions of “Urgency” in Women With Interstitial Cystitis/Bladder Pain Syndrome or Overactive Bladder.  J Urol Apr 2012;187(4):1353
  124. Wein AJ.  Re:  Pelvic Floor Exercise for Urinary Incontinence: A Systematic Literature Review.  J Urol Apr 2012;187(4):1353-1354
  125. Wein AJ.  Re:  A Qualitative Study of Women’s Preferences for Treatment of Pelvic Floor Disorders.  J Urol Apr 2012;187(4):1354-1355
  126. Wein AJ.  Re:  Bladder Neck Closure and Suprapubic Catheter Placement as Definitive Management of Neurogenic Bladder.  J Urol Apr 2012;187(4):1355-1356
  127. Abrams P, Cardozo L, Wein A.  Editorial—3rd International Consultation on Incontinence—Research Society 2011.  Neurourology and Urodynamics 31:291-292 (2012)
  128. Wein AJ.  Re: Promise of Urinary Nerve Growth Factor for Assessment of Overactive Bladder Syndrome.  J Urol May 2012;187(5):1747-1748
  129. Wein AJ.  Re:  Rectal Distension: The Effect on Bladder Function.  J Urol May 2012;187(5):1748
  130. Wein AJ.  Re:  Contemporary Management of Postprostatectomy Incontinence.  J Urol May 2012;187(5):1749
  131. Wein AJ.  Re: The role of Invasive and Non-Invasive Urodynamics in Male Voiding Lower Urinary Tract Symptoms.  J Urol May 2012;187(5):1750
  132. Wein AJ.  Re: Silodosin Therapy for Lower Urinary Tract Symptoms in Men With Suspected Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe.  J Urol May 2012;187(5):1751-1752
  133. Boopathi E, Hypolite J, Zderic S, Wein A, Chacko S.  GATA-6 and NF-KB Synergistically Upregulates CPI-17 Gene Expression in Obstruction-Induced Murine Bladder Smooth Muscle Hypertrophy (Abstract #490, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 20, 2012)
  134. Lei Q, Pan X-Q, Asfaw T, Hypolite J, Wein A, Malykhina A.  Development of a Neurogenic Bladder in Transient Receptor Potential Vanilloid 1 Knockout Mice.  (Abstract #493, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 20, 2012)
  135. Lei Q, Hypolite J, Chang S, Seftel R, Chacko S, Wein A, Seftel A, Malykhina A.  Impairment of Sensory Innervation in the Bladder Neck by  Outlet Obstruction Contributes to the Development of Erectile Dysfunction.  (Abstract #1006, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 21, 2012)
  136. Ravishankar J, Chhatre S, Wein A, Malkowicz SB.  Association of Prostate Cancer Treatment with Satisfaction with Care and Utility.  (Abstract #1629, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 17, 2012)
  137. Boopathi E, Zderic S, Addya S, Fortina P, Wein A, Chacko S.  Down-Regulation of large Conductance, Calcium-Activated K+ Channel Gene Expression in Mice and Human Detrusor Smooth Muscle Following Partial Bladder Outlet Obstruction:  Effects of Stretch and Hypoxia.  (Abstract #1965, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 22, 2012)
  138. Weiss B, Wein A, Malkowicz SB, Guzzo T.  Comparison of Prostate Volume Measured by Transrectal Ultrasound and Magnetic Resonance Imaging.  (Abstract #2052, presented at the Annual Meeting of the American Urological Association, Atlanta, GA (USA), May 23, 2012)
  139. Wein AJ.  Re: Detrusor Underactivity: A Plea for New Approaches to a Common Bladder Dysfunction.  J Urol June 2012;187(6):2154-2155
  140. Wein AJ.  Re: Neural Control of the Female Urethral and Anal Rhabdosphincters and Pelvic Floor Muscles.  –and–  Re:  Properties of Urethral Rhabdosphincter Motoneurons and Their Regulation by Noradrenaline.  J Urol June 2012;187(6):2155-2156
  141. Wein AJ.  Re: Duloxetine for Mild to Moderate Postprostatectomy Incontinence: Preliminary Results of a Randomised, Placebo-Controlled Trial.  J Urol June 2012;187(6):2156-2157
  142. Wein AJ.  Re: Sacral Neuromodulation for Nonobstructive Urinary Retention: A Meta-Analysis. 
    J Urol July 2012;188(1):222
  143. Wein AJ.  Re: Interstim Sacral Neuromodulation and Botox Botulinum-A Toxin Intradetrusor Injections for Refractory Urge Urinary Incontinence: A Decision Analysis Comparing Outcomes Including Efficacy and Complications.  J Urol July 2012;188(1):223
  144. Wein AJ.  Re: SUI Surgery at the Time of Vaginal POP Repair:  Is a Surgical Algorithm Possible or Desirable?  J Urol Aug 2012;188(2):507-508
  145. Wein AJ.  Re: Prevalence o Urinary Urgency Symptoms Decreases by Mid-Urethral Sling Procedures for Treatment of Stress Incontinence.  J Urol Aug 2012;188(2):508
  146. Wein AJ.  Re:  Antimuscarinic Mechanisms and the Overactive Detrusor:  An Update.  J Urol Sept 2012;188(3);888-889
  147. Wein AJ.  Re:  Pharmacodynamics of Overactive Bladder Drugs:  Shifting the Curve.  – and – Women’s Perspective of Botulinum Toxin Treatment for Overactive Bladders Symptoms.  J Urol Sept 2012;188(3);889-890
  148. Wein AJ.  Re:  Urological Outcome After Myelomeningocele: 20 Years of Follow-up. J Urol Sept 2012;188(3);890-891
  149. Wein AJ.  Re:  Defining Cure.  J Urol Oct 2012;188(4);1231
  150. Wein AJ.  Re:  Incontinence Improves in Older Women After Intensive Pelvic Floor Muscle Training:  An Assessor-Blinded Randomized Controlled Trial.  J Urol Oct 2012;188(4);1232
  151. Wein AJ.  Re:  Reducing Nocturia in the Elderly:  A Randomized Placebo-Controlled Trial of Staggered Furosemide and Desmopressin.  J Urol Oct 2012;188(4);1232-1233
  152. Wein AJ.  Re:  Nocturia and Quality of Life:  Results from the Boston Area Community Health Survey.  J Urol Oct 2012;188(4);1233-1234
  153. Wein AJ.  Re:  Surgical Management of Pelvic Organ Prolapse in Women:  The Updated Summary Version Cochrane Review.  J Urol Nov 2012;188(5):1842-1843
  154. Wein AJ.  Re:  Guidelines for Providing Privileges and Credentials to Physicians for Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse.  J Urol Dec 2012;188(6);Part 1of 2;2300-2301
  155. Wein AJ.  Re:  The Efficacy and Safety of PSD503 (Phenylephrine 20%, w/w) for Topical Application in Women with Stress Urinary Incontinence.  A Phrase II, Multicentre, Double-Blind, Placebo Controlled, 2-Way Cross Over Study.  J Urol Dec 2012;188(6);Part 1of 2;2301-2302
  156. Wein AJ.  Re:  Urethral Injection Therapy for Urinary Incontinence in Women.  J Urol Dec 2012;188(6);Part 1of 2;2302-2303
  157. Wein AJ.  Re:  The Clinical Relevance of Cell-Based Therapy for the Treatment of Stress Urinary Incontinence.  Re:  Stem Cell Therapy:  A Future Treatment of Stress Urinary Incontinence.  Re:  Will We Ever Use Stem Cells for the Treatment of SUI?  ICI-RS 2011.  J Urol Dec 2012;188(6);Part 1of 2;2303-2305
  158. Wein AJ:  Re:  Can Maximum Urethral Closure Pressure (MUCP) be Used to Predict Outcome of Surgical Treatment of Stress Urinary Incontinence?  J Urol Dec 2012;188(6)Part 1of 2;2305-2306
  159. Wein AJ:  Re:  Should We Treat Lower Urinary Tract Symptoms without a Definitive Diagnosis?  No.  J Urol 2013;189(1)223-224
  160. Wein AJ:  Re:  Constructing Trials to Show Whether Urodynamic Studies are Necessary in Lower Urinary Tract Dysfunction.  J Urol 2013;189(1);224
  161. Wein AJ:  Re:  The Correlation Between Clinical and Urodynamic Diagnosis in Classifying the Type of Urinary Incontinence in Women.  A Systematic Review of the Literature.  J Urol 2013;189(1):225
  162. Wein AJ:  Re:  Smoking and Bladder Symptoms in Women.  J Urol Feb 2013;189(2):609-610
  163. Wein AJ:  Re:  Nocturia Think Tank:  Focus on Nocturnal Polyuria:  ICI-RS 2011.  J Urol Feb 2013;189(2):610
  164. Wein AJ:  Re:  Is On-Demand Sacral Neuromodulation in Patients with OAB Syndrome a Feasible Therapy Regime?  Re:  Magnetic Resonance Imaging Following InterStim®:  An Institutional Experience with Imaging Safety and Patient Satisfaction.  J Urol Feb 2013;189(2):610-611
  165. Wein AJ:  Re:  The Prevalence of Clinically Meaningful Overactie Bladder:  Bother and Quality of Life Results from the Population-Based FINNO Study.  J Urol Feb 2013;189(2):611-612
  166. Wein AJ:  Re:  Quality of Life in Complete Spinal Cord Injury Patients with a Brindley Bladder Stimulator Compared to a Matched Control Group.  J Urol Feb 2013;189(2):613
  167. Wein AJ:  Re:  Antimuscarinic Effects on Current Perception Threshold: A Prospective Placebo Control Study.  J Urol Mar 2013;189(3):999
  168. Wein AJ:  Re:  Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence. 
    J Urol Mar 2013;189(3):1000
  169. Wein AJRe:  Vaginal Support Pessaries:  Indications for Use and Fitting Strategies.  Re:  Pessary Care:  Follow up and Management of Complications.  Re:  Managing a Pessary Business.  J Urol Apr 2013;189(4):1444
  170. Wein AJ:  Re:  A Midurethral Sling to Reduce Incontinence After Vaginal Prolapse Repair.  J Urol Apr 2013;189(4):1445
  171. Wein AJRe:  Factors Associated with Urge Urinary Incontinence After Surgery for Stress Urinary Incontinence.  Re:  Persistence of Urgency and Urge Urinary Incontinence in Women with Mixed Urinary Symptoms After Midurethral Slings: A Multivariate Analysis. J Urol Apr 2013;189(4):1446-1447.
  172. Wein AJ:  Re:  A Randomized Trial of Urodynamic Testing Before Stress-Incontinence Surgery. 
    J Urol Apr 2013;189(4):1447
  173. Wein AJ:  Re:  Impact of Surgically Induced Weight Loss on Pelvic Floor Disorders.  J Urol May 2013;189(5):1817
  174. Wein AJ:  Re:  Determining the Optimal Pelvic Floor Muscle Training Regimen for Women with Stress Urinary Incontinence.  J Urol May 2013;189(5):1818
  175. Wein AJ:  Re:  The Efficacy of Posterior Tibial Nerve Stimulation for the Treatment of Overactive Bladder in Women:  A Systematic Review.  Re:  Effectiveness of Percutaneous Posterior Tibial Nerve Stimulation for Overactive Bladder:  A Systematic Review and Meta-Analysis.   J Urol June 2013;189(6):2202-2203
  176. Wein AJ:  Re:  Association of Overactive Bladder and C-Reactive Protein Levels.  Results from the Boston Area Community Health (BACH) Survey.  J Urol June 2013;189(6):2203-2204
  177. Wein AJ:  Re:  Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder:  Results from a Randomised European-Australian Phase 3 Trial.  Re:  Randomized Double-Blind, Active-Controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder.  Urol June 2013;189(6):2204-2205
  178. Wein AJ:  Re:  OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients with Urinary Incontinence due to Idiopathic Overactive Bladder:  A 36-Week Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial.  Re:  Onabotulinumtoxin A for Idiopathic Overactive Bladder: Raising the Bar. J Urol June 2013;189(6):2205-2206
  179. Smith Z, Pietzak E, Meise C, Mucksavage P, Van Arsdalen K, Wein A, Malkowicz SB, Guzzo T.  Simplification of the Fuhrman Grading System Does Not Affect Its Prognostic Ability in Patients with Clear Cell Renal Cell Carcinoma.  (Abstract #726, presented at the 108th Annual Meeting of the American Urological Association, San Diego, CA (USA), May 6, 2013)
  180. Smith Z, El Tayeb M, Mucksavage P, Van Arsdalen K, Wein A, Malkowicz SB, Guzzo T.  Intraoperative Frozen Section Analysis at Partial Nephrectomy:  Is It Necessary?  A Review of 370 Patients.  (Abstract #1446, presented at the 108th Annual Meeting of the American Urological Association, San Diego, CA (USA), May 7, 2013)
  181. Pietzak EJ, Resnick MJ, Mucksavage P, Van Arsdalen K, Wein AJ, Malkowicz SB, Guzzo TJ.  The Effect of Prostate Volume on The Detection of Clinically Insignificant Cancer on Repeat Prostate Biopsies.  (Abstract #2222, presented at the 108th Annual Meeting of the American Urological Association, San Diego, CA (USA), May 8, 2013)
  182. Wein AJ.  Re:  Nocturia is Associated with an Increased Risk of Coronary Heart Disease and Death. 
    J Urol July 2013;190(1):194
  183. Wein AJ.  Re:  Biofeedback for the Treatment of Female Pelvic Floor Muscle Dysfunction:  A Systematic Review and Meta-Analysis.  J Urol July 2013;190(1):194
  184. Wein AJ.  Re:  Maximum Urethral Closure Pressure in Women:  Normative Data and Evaluation as a Diagnostic Test.  J Urol July 2013;190(1):195
  185. Wein AJ.  Re:  Can Preoperative Urodynamic Investigation be Omitted in Women with Stress Urinary Incontinence?  A Non-Inferiority Randomized Controlled Trial.  J Urol August 2013;190(2);620
  186. Wein AJ.  Re: Native Tissue Repairs in Anterior Vaginal Prolapse Surgery: Examining Definitions of Surgical Success in the Mesh Era.  Re: Vaginal Mesh Update.  Re: Con: Mesh in Vaginal Surgery: Do the Risks Outweigh the Benefits?  Re: Pro: The Contemporary Use of Transvaginal Mesh in Surgery for Pelvic Organ Prolapse.  Re: Complications of Vaginal Mesh Surgery.  J Urol August 2013;190(2):621
  187. Wein AJ.  Re:  A Contemporary Assessment of Nocturia:  Definition, Epidemiology, Pathophysiology, and Management – A Systematic Review and Meta-Analysis.  J Urol September 2013;190(3):973
  188. Wein AJ.  Re:  Incontinence-Associated Dermatitis: Consensus Statements, Evidence-Based Guidelines for Prevention and Treatment, and Current Challenges.  J Urol September 2013;190(3):973-974
  189. Wein AJ.  Re:  A Systematic Review and Meta-Analysis of Macroplastique for Treating Female Stress Urinary Incontinence.  Re:  Two-Year Follow-up of an Open-Label Multicenter Study of Polyacrylamide Hydrogel (Bulkamid®) for Female Stress and Stress-Predominant Mixed Incontinence.  J Urol September 2013;190(3):974
  190. Wein AJ.  Re:  Transvaginal Mesh Kits—How “Serious” are the Complications and are they Reversible?  J Urol September 2013;190(3):974-975
  191. Wein AJ.  Re:  The Role of Prostanoids in Urinary Bladder Physiology.  J Urol September 2013;190(3):1132
  192. Wein AJ, Griebling T.  Re:  Persistence with Prescribed Antimuscarinic Therapy for Overactive Bladder:  A UK Experience.  J Urol October 2013;190(4):1328
  193. Wein AJ.  Re:  When are Urodynamics Indicated in Patients with Stress Urinary Incontinence?  J Urol October 2013;190(4):1329
  194. Wein AJ.  Re:  Chronic Urinary Retention in Men: How We Define I, and How Does It Affect Treatment Outcome.  J Urol October 2013;190(4):1330
  195. Wein AJ.  Re:  Effect of Physical Training on Urinary Incontinence:  A Randomized Parallel Group Trial in Nursing Homes.  J Urol October 2013;190(4):1330
  196. Wein AJ.  Re:  Long-Term Outcome of the Use of Intravesical Botulinum Toxin for the Treatment of Overactive Bladder (OAB).  J Urol November 2013;190(5):1815
  197. Wein AJ.  Re:  Anticholinergic Drugs for Adult Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis.  J Urol November 2013;190(5):1815-1816
  198. Wein AJ.  Re:  The Prevalence and Natural History of Urinary Symptoms among Recreational Katamine Users.  J Urol November 2013;190(5):1816
  199. Wein AJ.  Re:  Sexual Activity and Function in Women  More than 2 Years after Midurethral Sling Placement.  Re:  Vaginal Symptoms and Sexual Function after Tension-Free Vaginal Tape-Obturator Placement: Minimum 12-Month Follow-up.  J Urol November 2013;190(5):1840
  200. Griebling TL, Wein AJ.  Re:  The Passive and Active Contractile Properties of the Neurogenic, Underactive Bladder.  J Urol November 2013;190(5):1955
  201. Wein AJ.  Re:  A Systematic Review of Amnestic and Non-Amnestic Mild Cognitive Impairment Induced by Anticholinergic, Antihistamine, GABAergic and Opioid Drugs.  J Urol December 2013;190(6):2168
  202. Wein AJ.  Re:  Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions:  A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.  J Urol December 2013;190(6):2168-2169
  203. Wein AJ.  Re:  Feedback or Biofeedback to Augment Pelvic Floor Muscle Training for Urinary  Incontinence in Women:  Shortened Version of a Cochrane Systematic Review.  J Urol December 2013;190(6):2169
  204. Wein AJ:  Re:  Urothelial Signaling.  J Urol December 2013;190(6):2307-2308
  205. Wein AJ:  Re:  Benefits and Harms of Pharmacologic Treatment for Urinary Incontinence in Women:  A Systematic Review.  J Urol January 2014;191(1):155
  206. Wein AJ:  Re:  Finding Unrecognized Information in Overactive Bladder Clinical Trial Data:  A New Approach to Understanding Placebo and Treatment Effects.  J Urol January 2014;191(1):155-156
  207. Wein AJ:  Re:  Long-Term Durability of the Response to Desmopressin in Female and Male Nocturia Patients.  J Urol January 2014;191(1):156
  208. Wein AJ:  Re:  Neural Pathways Involved in Sacral Neuromodulation of Reflex Bladder Activity in Cats.  J Urol January 2014;191(1):271-272
  209. Wein AJ:  Re:  Effects of Oral Rho Kinase Inhibitor Fasudil on Detrusor Overactivity after Bladder Outlet Obstruction in Rats.  J Urol January 2014;191(1):272
  210. Wein AJ:  Re:  Impact of Hydrophilic Catheters on Urinary Tract Infections in People with Spinal Cord Injury:  Systematic Review and Meta-Analysis of Randomized Controlled Trials.  J Urol February 2014;191(2):371
  211. Wein AJ:  Re:  Incontinence:  Do Urodynamics Help Surgeons Know When Not to Operate?  J Urol February 2014;191(2):418
  212. Wein AJ:  Re:  Miniarc Single-Incision Sling for Treatment of Stress Urinary Incontinence:  2-Year Clinical Outcomes.  Re:  The MinArc Sling for Female Stress Urinary Incontinence:  Clinical Results after 1-Year Follow-up.  J Urol February 2014;191(2):418-419
  213. Wein AJ:  Re:  Long-Term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse.  J Urol February 2014;191(2):419
  214. Wein AJ:  Re:  Immediate Effects of the Initial FDA Notification on the Use of Surgical Mesh for Pelvic Organ Prolapse Surgery in Medicare Beneficiaries.  J Urol February 2014;191(2):420
  215. Wein AJ:  Re:  Solifenacin plus Tamsulosin Combination Treatment in Men with Lower Urinary Tract Symptoms and Bladder Outlet Obstruction:  A Randomized Controlled Trial.  J Urol March 2014;191(3):739
  216. Wein AJ:  Re:  Randomised, Multicentre, Placebo-Controlled, Double-Blind Crossover Study Investigating the Effect of Solifenacin and Oxybutynin in Elderly People with Mild Cognitive Impairment:  The SENIOR Study.  J Urol March 2014;191(3):739-740
  217. Wein AJ:  Re:  Inhibition of Bladder Overactivity by a Combination of Tibial Neuromodulation and Tramadol Treatment in Cats.  J Urol March 2014;191(3):868-869
  218. Wein AJ:  Re:  Autonomic Nervous Control of the Urinary Bladder.  J Urol March 2014;191(3):869
  219. Wein AJ:  Re:  Loss of β1-Integrin from Urothelium Results in Overactive Bladder and Incontinence in Mice:  A Mechanosensory Rather than Structure Phenotype.  J Urol March 2014;191(3):869-870
  220. Wein AJ:  Re:  Impact of the 2011 FDA Transvaginal Mesh Safety Update on AUGS Members’ Use of Synthetic Mesh and Biologic Grafts in Pelvic Reconstructive Surgery.  Re:  Position Statement on Restriction of Surgical Options for Pelvic Floor Disorders.  J Urol April 2014;191(4):1051-1052
  221. Wein AJ.  Re:  Open Retropubic Colposuspension for Urinary Incontinence in Women.  Re:  Surgical Management of Female SUI: Is There a Gold Standard?  J Urol April 2014;191(4):1052
  222. Wein AJ.  Re:  Female Urinary Incontinence:  Patient-Reported Outcomes 1 Year after Midurethral Sling Operations.  J Urol April 2014;191(4):1053
  223. Wein AJ.  Re:  The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: Focus on Outcomes of Therapy.  J Urol April 2014;191(4):1053-1054
  224. Wein AJ.  Re: Correlation Between Cystometric Volumes, ATP Release, and pH in Women with Overactive Bladder versus Controls.  Re:  The Regulation of ATP Release from the Urothelium by Adenosine and Transepithelial Potential.  J Urol April 2014;191(4):1054
  225. Weiss JP, Wein AJ, Van Kerrebroeck P.  Introduction and Meeting Recap.  (Abstract) Neurourology and Urodynamics 33:S1 (2014)
  226. Weiss JP, Wein AJ, Van Kerrebroeck P.  Future Research Guidance for Nocturia.  (Abstract) Neurourology and Urodynamics 33:S25 (2014)
  227. Wein AJ.  Re:  The Prevalence of Lower Urinary Tract Symptoms (LUTS) and Overactive Bladder (OAB) by Racial/Ethnic Group and Age:  Results from OAB-POLL.  J Urol May 2014;191(5):1340
  228. Wein AJ:  Re:  Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity. 
    J Urol May 2014;191(5):1340-1341
  229. Wein AJ:  Re:  Urinary Incontinence in Young Nulligravid Women:  A Cross-Sectional Analysis. 
    J Urol May 2014;191(5):1341
  230. Wein AJ:  Re:  Urethral Sphincter Function Before and After Radical Prostatectomy:  Systematic Review of the Prognostic Value of Various Assessment Techniques.  J Urol May 2014;191(5):1341-1342
  231. Wein AJ:  Re:  Risk Factors for the Failure of Antimuscarinic Treatment with Solifenacin in Women with Overactive Bladder.  J Urol June 2014;191(6):1822
  232. Wein AJ:  Re:  Cystectomy for Ulcerative Interstitial Cystitis: Sequelae and Patients’ Perceptions of Improvement.  J Urol June 2014;191(6):1823
  233. Wein AJ:  Re:  Long-Term Results of Artificial Urinary Sphincter for Women with Type III Stress Urinary Incontinence.  J Urol June 2014;191(6):1823-1824
  234. Wein AJ:  Re:  The Artificial Urinary Sphincter after a Quarter of a Century: A Critical Systematic Review of its Use in Male Non-Neurogenic Incontinence.  J Urol June 2014;191(6):1824
  235. Wein AJ:  Re:  Transcorporal Artificial Urinary Sphincter Implantation as a Salvage Surgical Procedure for Challenging Cases of Male Stress Urinary Incontinence: Surgical Technique and Functional Outcomes in a Contemporary Series.  J Urol June 2014;191(6):1824-1825
  236. Wein AJ:  Re:  Risk Factors for Incomplete Bladder Emptying after Midurethral Sling.  J Urol July 2014;192(1):157
  237. Wein AJ:  Re:  Three-Year Results from a Randomised Trial of a Retropubic Mid-Urethral Sling versus the Miniarc Single Incision Sling for Stress Urinary Incontinence.  J Urol July 2014:192(1):157-158
  238. Wein AJ:  Re:  Comparison of an Adjustable Anchored Single-Incision Mini-Sling, Ajust®, with a Standard Mid-Urethral Sling, TVT-O™: A Health Economic Evaluation.  J Urol July 2014;192(1):158
  239. Wein AJ:  Re:  The Use of Botulinum Toxin for the Treatment of Urologic Pain.  J Urol July 2014;192(1):158-159
  240. Wein AJ:  Re:  OnabotulinumtoxinA Significantly Attenuates Bladder Afferent Nerve Firing and Inhibits ATP Release from the Urothelium.  J Urol July 2014;192(1):276-277
  241. Wein AJ:  Re:  The Role of Phosphodiesterases in Bladder Pathophysiology.  J Urol August 2014;192(2):488
  242. Wein AJ:  Re:  A Systematic Review of Surgical Techniques Used in the Treatment of Female Urethral Stricture.  J Urol August 2014;192(2)488-489
  243. Wein AJ:  Re:  TVT-O for the Treatment of Pure Urodynamic Stress Incontinence: Efficacy, Adverse Effects, and Prognostic Factors at 5-Year Follow-up.  J Urol August 2014;192(2):489
  244. Wein AJ:  Re:  Chronic Administration of Anticholinergics in Rats Induces a Shift from Muscarinic to Purinergic Transmission in the Bladder Wall.  J Urol August 2014;192(2):616
  245. Wein AJ:  Re:  β3-Receptor Agonists for Overactive Bladder—New Frontier or More of the Same? 
    J Urol September 2014;192(3):861
  246. Wein AJ:  Re:  Mirabegron for Male Lower Tract Symptoms. J Urol September 2014;192(3):861-862
  247. Wein AJ:  Re:  Current Status of Bulking Agents for Urinary Incontinence. J Urol September 2014;192(3):862
  248. Wein AJ:  Re:  Long-Term Follow-up after Regenerative Therapy of the Urethral Sphincter for Female Stress Urinary Incontinence. J Urol September 2014;192(3):862
  249. Wein AJ:  Re:  Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery after Radical Prostatectomy. J Urol September 2014;192(3):863
  250. Wein AJ:  Re:  An Evidence-Based Approach to Urodynamic Testing.  J Urol October 2014;192(4):1162
  251. Wein AJ:  Re:  Are the Measurements of Water-Filled and Air-Charged Catheters the Same in Urodynamics?  J Urol October 2014;192(4):1163
  252. Wein AJ:  Re:  Nerve Growth Factor (NGF):  A Potential Urinary Biomarker for Overactive Bladder Syndrome (OAB)?  J Urol October 2014;192(4):1163
  253. Wein AJ:  Re:  Neural Pathways Involved in Sacral Neuromodulation of Reflex Bladder Activity in Cats.  J Urol October 2014;192(4):1296
  254. Wein AJ:  Re:  An alpha1-Adrenoceptor Blocker Terazosin Improves Urine Storage Function in the Spinal Cord in Spinal Cord Injured Rats.  J Urol October 2014;192(4):1296
  255. Wein AJ:  Re:  Outcomes of Observation as Therapy for Pelvic Organ Prolapse:  A Study in the National History of Pelvic Organ Prolapse.  J Urol November 2014;192(5):1489
  256. Wein AJ:  Re:  Changes in Tissue Composition of the Vaginal Wall of Premenopausal Women with Prolapse.  J Urol November 2014;192(5):1489
  257. Wein AJ:  Re:  The Case for Robotics in Pelvic Prolapse Surgery, and, Re:  Robot-Assisted Sacrocolpopexy for Pelvic Organ Prolapse: Surgical Technique and Outcomes at a Single High-Volume Institution.  J Urol November 2014;192(5):1490
  258. Wein AJ:  Re:  The Effect of Pelvic Organ Prolapse Severity on Improvement in Overactive Bladder Symptoms after Pelvic Reconstructive Surgery, and, Re:  Urgency Resolution Following Prolapse Surgery: Is Voiding Important?  J Urol November 2014;192(5):1490-1491
  259. Wein AJ:  Re:  Seventeen Years’ Follow-up of the Tension-Free Vaginal Tape Procedure for Female Stress Urinary Incontinence, and, Re:  Long-Term Follow-up of the Retropubic Tension-Free Vaginal Tape Procedure, and, Re:  Nothing Lasts Forever?  Long-Term Outcomes of Stress Urinary Incontinence Surgery.  J Urol November 2014;192(5):1491-1492
  260. Wein AJ:  Re:  Update on Behavioral and Physical Therapies for Incontinence and Overactive Bladder:  The Role of Pelvic Floor Muscle Training.  J Urol December 2014;192(6):1762-1763
  261. Wein AJ:  Re:  Nocturia Causes Vary with Each Decade.  J Urol December 2014;192(6):1763
  262. Wein AJ:  Re:  Global Prevalence and Economic Burden of Urgency Urinary Incontinence: A Systematic Review.  J Urol December 2014;192(6):1763-1764
  263. Wein AJ:  Re:  Postpartum Pelvic Floor Muscle Training and Urinary Incontinence: A Randomized Controlled Trial.  J Urol December 2014;192(6):1764
  264. Wein AJ:  Re:  Repeated Variate Stress in Male Rats Induces Increased Voiding Frequency, Somatic Sensitivity, and Urinary Bladder Nerve Growth Factor Expression.  J Urol December 2014;192(6):1885-1886
  265. Wein AJ:  Re:  Detrusor Underactivity in Men following Radical Retropubic Prostatectomy—Prevalence, Importance and Evaluation; Re: The Many Faces of Impaired Bladder Emptying. 
    J Urol January 2015;193(1):217-218
  266. Wein AJ:  Re:  The Pharmacological Rationale for Combining Muscarinic Receptor Antagonists and β-Adrenoceptor Agonists in the Treatment of Airway and Bladder Disease.  Re:  Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder:  Efficacy and Safety Results from a Randomised, Double-Blind, Dose-Ranging, Phase 2 Study (Symphony).  J Urol January 2015;193(1):218-219
  267. Wein AJ:  Re:  Urodynamic Studies for Management of Urinary Incontinence in Children and Adults.  J Urol January 2015;193(1):219
  268. Wein AJ:  Re:  Biomarkers in Lower Urinary Tract Symptoms/Overactive Bladder: A Critical Overview.  J Urol January 2015;193(1):219-220
  269. Wein AJ:  Re:  Pre-Operative Urodynamics in Women with Stress Urinary Incontinence Increases Physician Confidence, but Does Not Improve Outcomes.  J Urol January 2015;193(1):220
  270. Wein AJ:  Re:  Urinary Diversion in Patients with Spinal Cord Injury in the United States.  J Urol, February 2015;193(2):579
  271. Wein AJ:  Re:  Are Recurrence Rates for “Traditional” Transvaginal Prolapse Repairs Really that High?  What does the Evidence Show?  Re:  Evidence-Based Outcomes for Mesh-Based Surgery for Pelvic Organ Prolapse.  Re:  Repair of Pelvic Organ Prolapse: What is the Goal?  J Urol February 2015;193(2):605-606
  272. Wein AJ:  Re:  Implications of the FDA Statement on Transvaginal Placement of Mesh: The Aftermath.  J Urol February 2015;193(2):606-607
  273. Wein AJ:  Re:  Surgery versus Physiotherapy for Stress Urinary Incontinence.  J Urol February 2015;193(2):607
  274. Wein AJ:  Re:  Urgency after a Sling: Review of the Management.  J Urol February 2015;193(2):608
  275. Wein AJ:  Re:  Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavorial Therapy for Apical Vaginal Prolapse:  The OPTIMAL Randomized Trial.  J Urol March 2015;193(3):943-944
  276. Wein AJ:  Re:  Outcomes of Vaginal Prolapse Surgery among Female Medicare Beneficiaries:  The Role of Apical Support.  J Urol March 2015;193(3);944
  277. Wein AJ:  Re:  A Review of the Current Status of Laparoscopic and Robot-Assisted Sacrocolpopexy for Pelvic Organ Prolapse.  J Urol March 2015;193(3);944-945
  278. Wein AJ:  Re:  Paucity of Evidence for Urinary Tract Outcomes in Closed Spinal Dysraphism: A Systematic Review.  Re:  Adolescent Urology: Developing Lifelong Care for Congenital Anomalies.  J Urol March 2015;193(3):945-946
  279. Wein AJ:  Re:  Urodynamics:  Examining the Current Role of UDS Testing.  What is the Role of Urodynamic Testing in Light of Recent AUA Urodynamics and Overactive Bladder Guidelines and the VALUE Study?  J Urol April 2015;193(4):1311-1312
  280. Wein AJ.  Re:  Long-Term Functional Outcomes after Artificial Urinary Sphincter Implantation in Women with Stress Urinary Incontinence.  J Urol April 2015;193(4):1312
  281. Wein AJ.  Re: A Group-Based Yoga Therapy Intervention for Urinary Incontinence in Women: A Pilot Randomized Trial.  Re:  Comparison of Mindfulness-Based Stress Reduction versus Yoga on Urinary Urge Incontinence: A Randomized Pilot Study with 6-Month and 1-Year Follow-up Visits.  J Urol April 2015;193(4):1313
  282. Wein AJ:  Re:  Pilot Study of Liposome-Encapsulated Onabotulinumtoxina for Patients with Overactive Bladder: A Single-Center Study.  J Urol April 2015;193(4):1314
Books (last 5 years)
  1. Ellsworth P, Wein AJQuestions & Answers About Overactive Bladder, 2nd Edition, Jones and Bartlett Publishers, Sudbury, MA, Copyright © 2010
  2. Guzzo TG, Drach G, Wein AJ (eds):  Primer of Geriatric Urology, 1st Edition, 2011, published by Springer Science and Business Media, LLC, Philadelphia, Pennsylvania USA – (IN PRESS)
  3. Slack A, Newman DK, Wein AJ (eds):  Fast Facts: Bladder Disorders, 2nd Edition, 2011.  Health Press, Ltd, Abingdon Oxford, United Kingdom
  4. Wein AJ, Chapple C (eds):  Managing Overactive Bladder, Springer Healthcare, Ltd., London, United Kingdom – Copyright©2011
  5. Wein AJ (editor-in-chief), Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh Urology Tenth Edition, Saunders/Elsevier, Philadelphia, PA – Copyright©2012
  6. McDougal SW, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, Ramchandani P (eds): Campbell-Walsh Urology Tenth Edition Review, Elsevier/Saunders, Philadelphia, PA - Copyright©2012
  7. Weiss JP, Blaivas JG, Van Kerrebroeck PEV, Wein AJ (eds):  Nocturia: Causes, Consequences and Clinical Approaches.  Springer Science+Business Media, LLC.  Library of Congress Control Number:  2011939061 (2012)
  8. Abrams P, Cardozo L, Khoury S, Wein AW (eds).  INCONTINENCE 5th Edition 2013, 5th International Consultation on Incontinence, Paris, February, 2012.  Published by the ICUD and EAU 2013.
  9. Hanno PM, Guzzo TJ, Malkowicz SB, Wein AJ.  Penn Clinical Manual of Urology, Second Edition, Elsevier/Saunders, Inc., Philadelphia, PA (2014)
  10. Wein AJ, Andersson K-E, Drake MJ, Dmochowski RR.  Bladder Dysfunction in the Adult: The Basis for Clinical Management.  Springer/Humana Press, New York, 2014.
Alternative Media (last 5 years)
  1. Is Screening for Prostate Cancer Harmful? NBC 10, Oct 7, 2011
  2. Nocturia 101 from Penn Medicine Expert, Philadelphia Inquirer, March 9, 2012
  3. Warren Buffett's Prostate Cancer Diagnosis Brings Debate over PSA Screening KYW Newsradio 1060 AM, April 2012
  4. Penn Physicians Featured in 6ABC Q and A on Prostate Cancer, 6ABC, June 2012
  5. High School Rival Tackles Cancer, NJ.com, June 24, 2012
  6. PSA Screenings Under Attack, Jewish Exponent, July 19, 2012
  7. Botox Bladder Injections May Stop The 'Gotta-Go' Urge in Women, MSNBC.com, October 4, 2012
  8. Research Questions Prostate Cancer Care, Philadelphia Inquirer, July 16, 2014
  9. Featured Expert in a Three-Part Elsevier video series on prostate cancer for Elsevier online and their YouTube site; Series topics include: PSA Testing, Treatment Options for Prostate Cancer and other care issues – April 10, 2015.
 
Awards, Honors, and Memberships in Honorary Societies and By-Election Only
2015 America’s Top Doctors for Cancer
 
2014 Continence Care Champion Award from the National Association for Continence, presented at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction
 
2014 America’s Top Doctors for Cancer
 
2014 America’s Top Doctors
 
2012 Super Doctors 2012
 
2012  University of Pennsylvania Division of Urology Paul Rodin Leberman Teaching Award
(Recognition of Excellence in Resident Education), June 2012
 
2012 Edward L. Keyes Medal – AAGUS Award Ceremony, April 2012
 
2011 Ferdinand C. Valentine Award (New York Academy of Medicine) April 2011
 
2010 America’s Top Doctors for Cancer
 
2010 America’s Top Doctors
 
2010 Honorary Professor of the Federal State Institute of Urology
(Ministry of Healthcare and Social Development of the Russian Federation)
 
2009 - 2010 Best Doctors in America
 
2009 The 2009 American Urological Association Education and Research, Inc/Pfizer Visiting Professorship in Urology
 
2009 America’s Top Doctors for Cancer
 
2009 18th Annual National Mature Media AwardsSM Honoring the Best in Advertising, Marketing & Educational Materials for Older Adults for “Managing and Treating Urinary Incontinence 2nd Edition (honoring the Best in Advertising, Marketing & Educational Materials for Older Adults.  Media/Book)
 
2008 Philadelphia Top Doctors
 
2008 America’s Top Doctors for Cancer
 
2008 The Class of '32 Distinguished Alumni Award, The Mercersburg Academy
presented October 18, 2008 at the 50th Reunion of the Class of 1958
 
2008 Distinguished Service Award for Outstanding Contributions to Urodynamics, Female Urology and Voiding Dysfunction and Exemplary Service, Society for Urodynamics and Female Urology
 
2007 - 2008 Best Doctors in America
 
2006 America’s Top Doctors for Cancer
 
2005 - 2006 Best Doctors in America
 
2005 Philadelphia Top Doctors
 
2005 America’s Top Doctors for Cancer
 
2005 Honorary Ph.D. conferred by the University of Patras, Patras, Greece, September 2005
 
2003 America’s Top Doctors
 
2002 American Urological Association Lecturer at European Association of Urology
 
2001 - 2002 Best Doctors in America
 
2001 Recipient, Legion of Honor Gold Medallion from Chapel of Four Chaplains
Valley Forge, Pennsylvania
 
2001  America’s Top Doctors
 
2001 Distinguished Contribution Award, American Urological Association, Inc. for Contributions to the Science and Practice of Urology
 
2000 Distinguished Service Award, American Urological Association, Inc. for Education in Urology
 
1999 Robert Dunning Dripps Memorial Teaching Award, University of Pennsylvania School of Medicine
 
1999 British Journal of Urology Lecturer at British Association of Urological Surgery Meeting
 
1997 American Urological Association Lecturer at the Société Internationale d’Urologie
 
1997 Hugh Hampton Young Award, American Urological Association, Inc.
 
1996 Best Doctors in America 1996
 
1996 Ramon Guiteras Lecturer, American Urological Association, Inc.
 
1996  F. Brantley Scott Award, American Foundation for Urologic Disease, Inc.
 
1995 Society of Surgical Oncology
 
1994 Société Internationale de Chirurgie
 
1993 American Surgical Association
 
1992 Lifetime Achievement Award, Urodynamics Society (now known as the Society for Urodynamics and Female Urology
 
1992 William P. Burpeau Award, New Jersey Academy of Medicine, Section of Urology
 
1990 Honorary Award for achievements in the field and contribution to knowledge about IC,  Presented by Interstitial Cystitis Association
 
1990 Honorary Member, Southeastern Section, American Urological Association
 
1988 Clinical Society of Genitourinary Surgeons
 
1987 Second Prize, Lapides Essay Contest, American Urological Association
(Studies on the Biphasic Nature of Urinary Bladder Contraction and Function)
 
1984 American Association of Genitourinary Surgeons
 
1972 Second Prize, Philadelphia Urological Society Essay Contest
(The Effect of 6-Hydroxydopamine on Ureteral Contractility)
 
1971 Third Prize, Philadelphia Urological Society Essay Contest
(The Adrenergic Innervation of the Dog Ureter)
 
1970 First Prize, Philadelphia Urological Society Essay Contest
(The Effects of Isuprel on Ureteral and Bladder Contractility)
 
1969 Second Prize, Philadelphia Urological Society Essay Contest
(The Effects of Aminophylline on Ureteral Contractility)
 
1966 Alpha Omega Alpha, University of Pennsylvania
 
1962 Sigma Xi, Princeton University
 
1962 Cum Laude, Princeton University

Dr. Alan Wein

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine